Article
A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C.
BMC infectious diseases - 29 Oct 2020
Ramsay Jessica, Marsh Julie, Pedrana Alisa, Andric Nada, Norman Richard, Cheng Wendy, Webb Steve, Zeps Nikolajs, Bellgard Matthew, Graves Todd, Hellard Margaret, Snelling Tom
Abstract excerpt
BACKGROUND: Safe, highly curative, short course, direct acting antiviral (DAA) therapies are now available to treat chronic hepatitis C. DAA therapy is freely available to all adults chronically infected with the hepatitis C virus (HCV) in Australia. If left untreated, hepatitis C may lead to progressive hepatic fibrosis, cirrhosis and hepatocellular carcinoma. Australia is committed to eliminating hepatitis as a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.